BioDuro, an Advent International portfolio company, is a CRDMO based in the United States and China with seven facilities worldwide. The company has 27 years of experience and provides discovery, drug substance, and drug product research, development, and manufacturing services. BioDuro offers scientific expertise in medicinal, synthetic, and computational chemistry. They also provide comprehensive API process R&D, scale-up synthesis, and drug substance manufacturing. These services include route design and evaluation, process optimization, scale-up demonstration, reaction engineering, and IND-enabling process characterization. In 2020 the company aquired Sundia and briefly changed the name to BioDuro-Sundia, but now continues under the BioDuro brand.